BUZZ-Jefferies raises Eli Lilly PT on potential sales of sleep apnea drug

Reuters
2023.10.05 16:55
portai
I'm PortAI, I can summarize articles.

** Brokerage Jefferies raises its PT for Eli Lillyto $625 from $615

** Brokerage Jefferies raises its PT for Eli Lilly (LLY.N) to $625 from $615

** The new price target represents a 17.7% upside to the stock’s last close

** LLY’s diabetes medication Mounjaro can achieve about 50% peak market share of all the GLP-1’s in OSA (obstructive sleep apnea)- Jefferies

** GLP-1 drugs, originally developed to help control blood sugar in patients with type 2 diabetes, also suppress appetite and promote a feeling of fullness

** OSA is a disorder strongly associated with obesity where one’s airway passage gets disrupted during sleep

** Including session moves, LLY’s shares up ~47.5% YTD

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.